Published in Int J Mol Sci on August 05, 2013
Expression, regulation and function of microRNAs in multiple sclerosis. Int J Med Sci (2014) 1.03
Blood Biomarkers as Outcome Measures in Inflammatory Neurologic Diseases. Neurotherapeutics (2016) 0.90
Biomarkers of therapeutic response in multiple sclerosis: current status. Mol Diagn Ther (2014) 0.87
Natalizumab restores aberrant miRNA expression profile in multiple sclerosis and reveals a critical role for miR-20b. Ann Clin Transl Neurol (2014) 0.87
MicroRNA as Type I Interferon-Regulated Transcripts and Modulators of the Innate Immune Response. Front Immunol (2015) 0.86
Seeking balance: Potentiation and inhibition of multiple sclerosis autoimmune responses by IL-6 and IL-10. Cytokine (2015) 0.85
Regulatory role of small nucleolar RNAs in human diseases. Biomed Res Int (2015) 0.85
Circulating microRNAs as biomarkers for diffuse myocardial fibrosis in patients with hypertrophic cardiomyopathy. J Transl Med (2015) 0.85
Autologous hematopoietic SCT normalizes miR-16, -155 and -142-3p expression in multiple sclerosis patients. Bone Marrow Transplant (2014) 0.81
PGS: a tool for association study of high-dimensional microRNA expression data with repeated measures. Bioinformatics (2014) 0.80
MicroRNAs: The Role in Autoimmune Inflammation. Acta Naturae (2016) 0.78
Glatiramer acetate treatment effects on gene expression in monocytes of multiple sclerosis patients. J Neuroinflammation (2013) 0.78
SncRNA (microRNA &snoRNA) opposite expression pattern found in multiple sclerosis relapse and remission is sex dependent. Sci Rep (2016) 0.78
MicroRNA regulation in human CD8+ T cell subsets--cytokine exposure alone drives miR-146a expression. J Transl Med (2014) 0.78
Analysis of microRNA and Gene Expression Profiles in Multiple Sclerosis: Integrating Interaction Data to Uncover Regulatory Mechanisms. Sci Rep (2016) 0.77
miRNAs Participate in MS Pathological Processes and Its Therapeutic Response. Mediators Inflamm (2016) 0.77
Multiobjective triclustering of time-series transcriptome data reveals key genes of biological processes. BMC Bioinformatics (2015) 0.77
Dicer and microRNA expression in multiple sclerosis and response to interferon therapy. J Neuroimmunol (2016) 0.77
The Characterization of GSDMB Splicing and Backsplicing Profiles Identifies Novel Isoforms and a Circular RNA That Are Dysregulated in Multiple Sclerosis. Int J Mol Sci (2017) 0.75
Circulating microRNAs as biomarkers for rituximab therapy, in neuromyelitis optica (NMO). J Neuroinflammation (2016) 0.75
Editorial on the Special Issue: Regulation by non-coding RNAs. Int J Mol Sci (2013) 0.75
Meta-Analysis of Differential Connectivity in Gene Co-Expression Networks in Multiple Sclerosis. Int J Mol Sci (2016) 0.75
Fingolimod alters the transcriptome profile of circulating CD4+ cells in multiple sclerosis. Sci Rep (2017) 0.75
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Most mammalian mRNAs are conserved targets of microRNAs. Genome Res (2008) 37.16
Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol (2007) 37.10
A mammalian microRNA expression atlas based on small RNA library sequencing. Cell (2007) 34.03
Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics (2010) 26.76
miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res (2010) 25.85
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol (2011) 25.66
Identification of hundreds of conserved and nonconserved human microRNAs. Nat Genet (2005) 15.96
Multiple sclerosis. Lancet (2008) 13.77
MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A (2007) 11.42
miRWalk--database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform (2011) 8.50
MicroRNA control in the immune system: basic principles. Cell (2009) 7.16
Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature (2007) 7.04
Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov (2007) 6.33
miRTarBase: a database curates experimentally validated microRNA-target interactions. Nucleic Acids Res (2010) 5.72
The microRNA miR-29 controls innate and adaptive immune responses to intracellular bacterial infection by targeting interferon-γ. Nat Immunol (2011) 3.77
An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat Neurosci (2012) 2.90
MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. Brain (2009) 2.74
MicroRNA-29 regulates T-box transcription factors and interferon-γ production in helper T cells. Immunity (2011) 2.71
MicroRNA assassins: factors that regulate the disappearance of miRNAs. Nat Struct Mol Biol (2010) 2.42
Novel definition files for human GeneChips based on GeneAnnot. BMC Bioinformatics (2007) 2.32
Transcriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaB. J Cell Biochem (2010) 2.30
Multiple sclerosis: microRNA expression profiles accurately differentiate patients with relapsing-remitting disease from healthy controls. PLoS One (2009) 2.14
Differential micro RNA expression in PBMC from multiple sclerosis patients. PLoS One (2009) 1.98
MicroRNAs in neuronal function and dysfunction. Trends Neurosci (2012) 1.94
MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation. Nat Immunol (2010) 1.87
Genome-scale microRNA and small interfering RNA screens identify small RNA modulators of TRAIL-induced apoptosis pathway. Cancer Res (2007) 1.83
miRGen 2.0: a database of microRNA genomic information and regulation. Nucleic Acids Res (2009) 1.78
Regulated microRNAs in the CSF of patients with multiple sclerosis: a case-control study. Neurology (2012) 1.78
MicroRNA and mRNA expression profile screening in multiple sclerosis patients to unravel novel pathogenic steps and identify potential biomarkers. Neurosci Lett (2011) 1.64
MicroRNA regulation of IFN-beta protein expression: rapid and sensitive modulation of the innate immune response. J Immunol (2010) 1.61
Clinically isolated syndromes. Lancet Neurol (2012) 1.59
Structural basis for viral 5'-PPP-RNA recognition by human IFIT proteins. Nature (2013) 1.58
Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance. J Neuroinflammation (2012) 1.52
Circular RNAs: splicing's enigma variations. EMBO J (2013) 1.52
Altered expression of miR-17-5p in CD4+ lymphocytes of relapsing-remitting multiple sclerosis patients. Eur J Immunol (2010) 1.44
MirZ: an integrated microRNA expression atlas and target prediction resource. Nucleic Acids Res (2009) 1.44
Interferon-beta mechanisms of action in multiple sclerosis. Neurology (2010) 1.40
Identification of X-linked inhibitor of apoptosis-associated factor-1 as an interferon-stimulated gene that augments TRAIL Apo2L-induced apoptosis. J Biol Chem (2002) 1.35
miR-29ab1 deficiency identifies a negative feedback loop controlling Th1 bias that is dysregulated in multiple sclerosis. J Immunol (2012) 1.35
Therapy of MS. Clin Neurol Neurosurg (2010) 1.26
MicroRNA-301a regulation of a T-helper 17 immune response controls autoimmune demyelination. Proc Natl Acad Sci U S A (2012) 1.24
Differential regulation of the Let-7 family of microRNAs in CD4+ T cells alters IL-10 expression. J Immunol (2012) 1.23
Peripheral myelin protein 22 is regulated post-transcriptionally by miRNA-29a. Glia (2009) 1.22
Determinants of interferon β efficacy in patients with multiple sclerosis. Nat Rev Neurol (2011) 1.16
Circulating microRNAs as biomarkers for disease staging in multiple sclerosis. Ann Neurol (2013) 1.15
Glatiramer acetate treatment normalizes deregulated microRNA expression in relapsing remitting multiple sclerosis. PLoS One (2011) 1.10
Integrative modeling of transcriptional regulation in response to antirheumatic therapy. BMC Bioinformatics (2009) 1.04
Altered microRNA expression in B lymphocytes in multiple sclerosis: towards a better understanding of treatment effects. Clin Immunol (2012) 1.04
MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis. Autoimmun Rev (2011) 1.03
tRNA binding, structure, and localization of the human interferon-induced protein IFIT5. Mol Cell (2013) 1.01
Computational analysis of target hub gene repression regulated by multiple and cooperative miRNAs. Nucleic Acids Res (2012) 1.00
Treatment of multiple sclerosis: current concepts and future perspectives. J Neurol (2011) 0.98
IFN-beta1b induces transient and variable gene expression in relapsing-remitting multiple sclerosis patients independent of neutralizing antibodies or changes in IFN receptor RNA expression. J Interferon Cytokine Res (2008) 0.97
Integration of MicroRNA databases to study MicroRNAs associated with multiple sclerosis. Mol Neurobiol (2012) 0.97
Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients' individual gene expression in peripheral blood. Mol Neurobiol (2013) 0.96
miRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencing. J Neuroimmunol (2011) 0.95
MicroRNAs and Multiple Sclerosis. Autoimmune Dis (2010) 0.94
RepTar: a database of predicted cellular targets of host and viral miRNAs. Nucleic Acids Res (2010) 0.93
Sieving treatment biomarkers from blood gene-expression profiles: a pharmacogenomic update on two types of multiple sclerosis therapy. Pharmacogenomics (2011) 0.92
Expression and Genetic Analysis of MicroRNAs Involved in Multiple Sclerosis. Int J Mol Sci (2013) 0.91
miR-15a and 16-1 are downregulated in CD4+ T cells of multiple sclerosis relapsing patients. Int J Neurosci (2012) 0.89
Biological responsiveness to first injections of interferon-beta in patients with multiple sclerosis. J Neuroimmunol (2005) 0.89
Monitoring of multiple sclerosis immunotherapy: from single candidates to biomarker networks. J Neurol (2008) 0.88
Long-term genome-wide blood RNA expression profiles yield novel molecular response candidates for IFN-beta-1b treatment in relapsing remitting MS. Pharmacogenomics (2010) 0.86
Network analysis of transcriptional regulation in response to intramuscular interferon-β-1a multiple sclerosis treatment. Pharmacogenomics J (2010) 0.84
Interferon-related and other immune genes are downregulated in peripheral blood leukocytes in the luteal phase of the menstrual cycle. J Clin Endocrinol Metab (2004) 0.82
The interferon beta therapies for treatment of relapsing-remitting multiple sclerosis: are they equally efficacious? A comparative review of open-label studies evaluating the efficacy, safety, or dosing of different interferon beta formulations alone or in combination. Ther Adv Neurol Disord (2011) 0.82
Web resources for microRNA research. Adv Exp Med Biol (2013) 0.77
Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis. Cell Immunol (2005) 3.42
Gene expression signatures for tumor progression, tumor subtype, and tumor thickness in laser-microdissected melanoma tissues. Clin Cancer Res (2007) 2.62
Cis- and trans-acting gene regulation is associated with osteoarthritis. Am J Hum Genet (2006) 1.55
Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance. J Neuroinflammation (2012) 1.52
Constitutive upregulation of the transforming growth factor-beta pathway in rheumatoid arthritis synovial fibroblasts. Arthritis Res Ther (2007) 1.29
18F-FDG kinetics and gene expression in giant cell tumors. J Nucl Med (2004) 1.29
E2F1 in melanoma progression and metastasis. J Natl Cancer Inst (2009) 1.23
Gene expression profiling of peripheral blood mononuclear leukocytes from psoriasis patients identifies new immune regulatory molecules. Eur J Dermatol (2005) 1.20
Assessment of the immune capacity of mammary epithelial cells: comparison with mammary tissue after challenge with Escherichia coli. Vet Res (2009) 1.17
Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or osteoarthritis. Electrophoresis (2002) 1.16
Generation and characterization of immortalized rat pancreatic stellate cells. Am J Physiol Gastrointest Liver Physiol (2004) 1.15
Gene-expression profile of collagen-induced arthritis. J Autoimmun (2002) 1.13
Genomic sequence and transcriptional profile of the boundary between pericentromeric satellites and genes on human chromosome arm 10p. Genome Res (2003) 1.12
High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis. Arthritis Res Ther (2003) 1.09
Mechanisms of hypoxic gene regulation of angiogenesis factor Cyr61 in melanoma cells. J Biol Chem (2003) 1.08
Fusion of positron emission tomography (PET) and gene array data: a new approach for the correlative analysis of molecular biological and clinical data. IEEE Trans Med Imaging (2007) 1.06
MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis. Autoimmun Rev (2011) 1.03
Peroxisome proliferator-activated receptor gamma overexpression inhibits pro-fibrogenic activities of immortalised rat pancreatic stellate cells. J Cell Mol Med (2005) 1.02
Functional analysis of an arthritogenic synovial fibroblast. Arthritis Res Ther (2003) 1.02
Impact of angiogenesis-related gene expression on the tracer kinetics of 18F-FDG in colorectal tumors. J Nucl Med (2008) 1.01
Autoantibodies against the exocrine pancreas in autoimmune pancreatitis: gene and protein expression profiling and immunoassays identify pancreatic enzymes as a major target of the inflammatory process. Am J Gastroenterol (2010) 1.01
Identification of intra-group, inter-individual, and gene-specific variances in mRNA expression profiles in the rheumatoid arthritis synovial membrane. Arthritis Res Ther (2008) 1.00
Differential gene expression in pristane-induced arthritis susceptible DA versus resistant E3 rats. Arthritis Res Ther (2003) 0.98
The ancient mammalian KRAB zinc finger gene cluster on human chromosome 8q24.3 illustrates principles of C2H2 zinc finger evolution associated with unique expression profiles in human tissues. BMC Genomics (2010) 0.98
Cytoskeletal rearrangements in synovial fibroblasts as a novel pathophysiological determinant of modeled rheumatoid arthritis. PLoS Genet (2005) 0.97
Quantitative and kinetic profile of Wnt/β-catenin signaling components during human neural progenitor cell differentiation. Cell Mol Biol Lett (2011) 0.97
Integration of MicroRNA databases to study MicroRNAs associated with multiple sclerosis. Mol Neurobiol (2012) 0.97
Interferon-beta therapy in multiple sclerosis: the short-term and long-term effects on the patients' individual gene expression in peripheral blood. Mol Neurobiol (2013) 0.96
Association of a common polymorphism in the promoter of UCP2 with susceptibility to multiple sclerosis. J Mol Med (Berl) (2005) 0.96
Fine mapping of collagen-induced arthritis quantitative trait loci in an advanced intercross line. J Immunol (2006) 0.96
Mass spectrometric proteome analysis for profiling temperature-dependent changes of protein expression in wild-type Caenorhabditis elegans. Proteomics (2003) 0.96
Batch correction of microarray data substantially improves the identification of genes differentially expressed in rheumatoid arthritis and osteoarthritis. BMC Med Genomics (2012) 0.95
Rheumatoid arthritis, a complex multifactorial disease: on the way toward individualized medicine. Med Res Rev (2006) 0.94
Gene expression analysis identifies novel genes participating in early murine liver development and adult liver regeneration. Differentiation (2006) 0.94
Tumor-promoting role of signal transducer and activator of transcription (Stat)1 in late-stage melanoma growth. Clin Exp Metastasis (2010) 0.94
Bone marrow-derived pancreatic stellate cells in rats. Cell Res (2010) 0.93
Proteome analysis reveals disease-associated marker proteins to differentiate RA patients from other inflammatory joint diseases with the potential to monitor anti-TNFalpha therapy. Pathol Res Pract (2004) 0.92
Global epithelial cell transcriptional responses reveal Streptococcus pyogenes Fas regulator activity association with bacterial aggressiveness. Cell Microbiol (2005) 0.92
Expression of connexin26 in islets of Langerhans is associated with impaired glucose tolerance in patients with pancreatic adenocarcinoma. Pancreas (2004) 0.92
Lipopolysaccharide priming enhances expression of effectors of immune defence while decreasing expression of pro-inflammatory cytokines in mammary epithelia cells from cows. BMC Genomics (2012) 0.92
Inhibition of lymphocyte apoptosis by pancreatic stellate cells: impact of interleukin-15. Am J Physiol Gastrointest Liver Physiol (2005) 0.91
Inhibitory effects of interferon-gamma on activation of rat pancreatic stellate cells are mediated by STAT1 and involve down-regulation of CTGF expression. Cell Signal (2006) 0.90
mtDNA nt13708A variant increases the risk of multiple sclerosis. PLoS One (2008) 0.90
Deep brain stimulation in a rat model modulates TH, CaMKIIa and Homer1 gene expression. Eur J Neurosci (2007) 0.90
Identification of new quantitative trait loci in mice with collagen-induced arthritis. Arthritis Rheum (2004) 0.90
Proteome analysis of diseased joints from mice suffering from collagen-induced arthritis. Clin Chem Lab Med (2003) 0.90
Expressionview: visualization of quantitative trait loci and gene-expression data in Ensembl. Genome Biol (2003) 0.89
Robust computational reconstitution - a new method for the comparative analysis of gene expression in tissues and isolated cell fractions. BMC Bioinformatics (2006) 0.89
Impact of cell-proliferation-associated gene expression on 2-deoxy-2-[(18)f]fluoro-D-glucose (FDG) kinetics as measured by dynamic positron emission tomography (dPET) in colorectal tumors. Mol Imaging Biol (2010) 0.88
Immunomodulatory effects of holothurian triterpene glycosides on mammalian splenocytes determined by mass spectrometric proteome analysis. J Proteomics (2009) 0.88
A proinflammatory role for Fas in joints of mice with collagen-induced arthritis. Arthritis Res Ther (2004) 0.88
Expression profiling of a high-fertility mouse line by microarray analysis and qPCR. BMC Genomics (2008) 0.87
Protective mechanisms of respiratory tract Streptococci against Streptococcus pyogenes biofilm formation and epithelial cell infection. Appl Environ Microbiol (2012) 0.87
Five years later: the current status of the use of proteomics and transcriptomics in EMF research. Proteomics (2012) 0.87
Quality Assessment in Multiple Sclerosis Therapy (QUASIMS): a comparison of interferon beta therapies for relapsing-remitting multiple sclerosis. J Neurol (2007) 0.87
Epitope predictions indicate the presence of two distinct types of epitope-antibody-reactivities determined by epitope profiling of intravenous immunoglobulins. PLoS One (2013) 0.87
Overexpression of glial cell line-derived neurotrophic factor induces genes regulating migration and differentiation of neuronal progenitor cells. Exp Cell Res (2004) 0.86
Long-term genome-wide blood RNA expression profiles yield novel molecular response candidates for IFN-beta-1b treatment in relapsing remitting MS. Pharmacogenomics (2010) 0.86
In vitro transcriptome analysis of porcine choroid plexus epithelial cells in response to Streptococcus suis: release of pro-inflammatory cytokines and chemokines. Microbes Infect (2011) 0.86
Gene expression profile and synovial microcirculation at early stages of collagen-induced arthritis. Arthritis Res Ther (2005) 0.86
Long-lived plasma cells and memory B cells produce pathogenic anti-GAD65 autoantibodies in Stiff Person Syndrome. PLoS One (2010) 0.85
Tumour Fas ligand:Fas ratio greater than 1 is an independent marker of relative resistance to tamoxifen therapy in hormone receptor positive breast cancer. Breast Cancer Res (2002) 0.85
Adapted Boolean network models for extracellular matrix formation. BMC Syst Biol (2009) 0.84
Towards a proteome signature for invasive ductal breast carcinoma derived from label-free nanoscale LC-MS protein expression profiling of tumorous and glandular tissue. Anal Bioanal Chem (2009) 0.84
Characterization of ischemia/reperfusion-induced gene expression in experimental pancreas transplantation. Transplantation (2006) 0.84
Type VIII collagen modulates TGF-β1-induced proliferation of mesangial cells. J Am Soc Nephrol (2011) 0.84
Computational analysis of high-density peptide microarray data with application from systemic sclerosis to multiple sclerosis. Autoimmun Rev (2011) 0.84
Probing the epitope signatures of IgG antibodies in human serum from patients with autoimmune disease. Methods Mol Biol (2009) 0.84
Reassessment of blood gene expression markers for the prognosis of relapsing-remitting multiple sclerosis. PLoS One (2011) 0.83